Chief Marketing Officer and SVP, Marketing & Communications · GoodRx Holdings, Inc. (GDRX)

Babak Azad

A named executive officer of GoodRx in every fiscal year CompBrief holds from FY2019 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,209,197

Salary $366,500Stock awards $1,713,726

FY2021: $500,397

4th of 6 named executive officers at GoodRx by FY2022 total.

6 named officers on file for GoodRx, FY2022

Babak Azad’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • GDRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GoodRx’s whole pay program stands against its peers

  • GoodRx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GDRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 1, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Babak Azad’s full pay file as a PDF — free

More than this page: up to 10 years of Babak’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Babak Azad compensation by year

GoodRx Summary Compensation Table · all 4 fiscal years held
In US dollars, as GoodRx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022
Salary$73,958$325,000$333,000$366,500
Bonus$146,229$233,583$150$0
Stock awards$0$0$0$1,713,726
Option awards$0$1,699,560$0$0
Non-equity incentive$0$123,500$166,500$128,371
Pension and deferred compensation$0$0$0$0
All other$150$732$747$600
Total$220,337$2,382,375$500,397$2,209,197

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GoodRx Holdings, Inc. DEF 14A filed May 1, 2023, accession 0000950170-23-016311, and prior-year filings.

How this page was built: the GoodRx Holdings, Inc. filed document, accession 0000950170-23-016311. Every figure is read from that document and cited to the page and table it appears in. Filed May 1, 2023.

$220K
$2.4M
$500K
$2.2M
FY19
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU306,023$1,426,067—
Option125,000—$5.94

Per the Outstanding Equity Awards at Fiscal Year-End table in GoodRx Holdings, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2022 proxy (filed May 1, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-06-08Exercise or conversion—20,401—51,060
2023-06-08Tax withholding—7,055$5.4144,005
2023-06-08Exercise or conversion derivative—20,401$0.00265,220

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments GoodRx discloses, by trigger · FY2022
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Death$0$0$0$0

Per the Potential Payments Upon Termination or Change in Control table in GoodRx Holdings, Inc.'s FY2022 proxy. Estimates as the company printed them; a dash means it printed no figure.

GoodRx’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Raj BeriChief Operating Officer$16,965,153
Karsten VoermannChief Financial Officer$5,235,060
Romin NabieyChief Accounting Officer$2,272,963
Babak Azad · this pageChief Marketing Officer and SVP, Marketing & Communications$2,209,197
Trevor BezdekCo-Chief Executive Officer$537,005
Douglas HirschCo-Chief Executive Officer$507,290

The full GoodRx compensation record

free company brief

This page is one person within GoodRx's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GoodRx proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GoodRx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Babak Azad's compensation dossier · One-time report. No refunds.